ICU — SeaStar Medical Holding Share Price
0.000.00%
Last trade - 00:00- $22.90m
- $21.94m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | 0.41 | 1 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The Company is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The Company's technologies rely on science to provide life-saving solutions to critically ill patients. The Company develops and commercializes cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company uses its Selective Cytopheretic Device (SCD) technology platform to clinically validate several acute organ injury indications, including kidneys and lungs. Its investigational SCD is an extracorporeal synthetic membrane device designed to integrate into existing continuous renal replacement therapy (CRRT) systems that are commonly installed in hospitals throughout the United States.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- October 28th, 2020
- Public Since
- January 26th, 2021
- No. of Shareholders
- 76
- No. of Employees
- 12
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 3,016,778
- Address
- 3513 Brighton Blvd, Suite 410, DENVER, 80216
- Web
- https://seastarmedical.com
- Phone
- +1 8133626488
- Contact
- Jody Cain
- Auditors
- Armanino LLP
Upcoming Events for ICU
Q3 2024 SeaStar Medical Holding Corp Earnings Release
Similar to ICU
Accelerate Diagnostics
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
Agendia NV
NASDAQ Capital Market
FAQ
What is the SeaStar Medical Holding share price?
As of Today at 23:09 UTC, shares in SeaStar Medical Holding are trading at $7.21. This share price information is delayed by 15 minutes.
How has the SeaStar Medical Holding share price performed this year?
Shares in SeaStar Medical Holding last closed at $7.21 and the price had moved by -41.47% over the past 365 days. In terms of relative price strength the SeaStar Medical Holding share price has underperformed the S&P500 Index by -53.42% over the past year.
What are the analyst and broker recommendations for SeaStar Medical Holding?
The overall consensus recommendation for SeaStar Medical Holding is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the SeaStar Medical Holding dividend yield?
SeaStar Medical Holding does not currently pay a dividend.
Does SeaStar Medical Holding pay a dividend?
SeaStar Medical Holding does not currently pay a dividend.
When does SeaStar Medical Holding next pay dividends?
SeaStar Medical Holding does not currently pay a dividend.
How do I buy SeaStar Medical Holding shares?
To buy shares in SeaStar Medical Holding you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of SeaStar Medical Holding?
As of the previous close price of $7.21, shares in SeaStar Medical Holding had a market capitalisation of $21.75m.
Where are SeaStar Medical Holding shares listed?
Here are the trading details for SeaStar Medical Holding:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: ICU
What kind of share is SeaStar Medical Holding?
Based on an overall assessment of its quality, value and momentum SeaStar Medical Holding is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a SeaStar Medical Holding share price forecast for 2024?
The analyst consensus target price for shares in SeaStar Medical Holding is $50.00. That is 593.48% above the last closing price of $7.21.
Analysts covering SeaStar Medical Holding currently have a consensus Earnings Per Share (EPS) forecast of -$9.50 for the next financial year.
What is the trend in the SeaStar Medical Holding share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SeaStar Medical Holding. Over the past six months, its share price has underperformed the S&P500 Index by -43.75%.
As of the last closing price of $7.21, shares in SeaStar Medical Holding were trading -49.54% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the SeaStar Medical Holding PE Ratio?
The SeaStar Medical Holding PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $7.21.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of SeaStar Medical Holding?
We do not have data on SeaStar Medical Holding's directors